Stories
Mobility
Sony and Honda's Afeela EV Venture Collapses Before It Ever Hit the Road
Sony and Honda's Afeela EV lineup has been cancelled just as the sedan neared production, exposing the brutal economics behind the software-defined car dream.
Health
Two Fatty Acids Show Promise in Clearing Senescent Cells Linked to Aging
Two polyunsaturated fatty acids found in bitter melon and tung oil can selectively kill senescent cells, adding an unexpected entry to the senolytic field.
Mobility
Google's Android Is Moving From Car Screens to Car Systems — and That Changes Everything
Google's Android is no longer just on car screens — it's taking over seats, climate systems, and more, raising deep questions about who really owns the car.
Mobility
The LaGuardia Controller Count Debate Obscures the Deeper Failures in U.S. Air Traffic Control
Sean Duffy says the lone-controller story is wrong, but the real question is whether the system around those controllers was ever adequate.
Mobility
Lamborghini's Temerario GT3 Reveals How Racing Became a Brand Engineering Lab
Lamborghini's fully in-house Temerario GT3 is less a race car than a rolling engineering laboratory with consequences far beyond the podium.
Mobility
Subaru's 420-HP Electric SUV Signals a Deeper Shift in the Family Car Market
Subaru's 420-horsepower electric SUV isn't just a new model, it's a stress test for one of America's most loyal automotive fanbases.
More Stories
Health
String Theory's Endless War: Why Physics Still Can't Quit Its Most Controversial Idea
Health
WHO's New TB Diagnostics Could Reshape How the World's Deadliest Infection Is Found
Health
Why American Cities Keep Building Bike Networks That Exclude Older Riders
Health
CRISPR Builds Cancer-Fighting Cells Inside the Body, Skipping the Lab Entirely
Advertisementinfeed_2
Mobility
Toyota Bets $800 Million on a Second U.S.-Built EV as Rivals Retreat
Toyota is investing $800 million in a second U.S.-built EV while rivals retreat, and its hybrid profits may be the reason it can afford to wait.
Health
Biological Age Tests Are Booming. The Science Behind Them Is Still Catching Up
Biological age tests are flooding the wellness market, but the science behind them is far murkier than the companies selling them want you to know.